2013 annual financial data

Innate Pharma S.A. - American Depositary Shares 2013 Operating margin

Innate Pharma S.A. - American Depositary Shares 2013 operating margin with veri…

Direct answer

Operating margin was -22.4%.

Operating income was -2,793,000 EUR and net income was -2,892,000 EUR.
Operating cash flow was -10,967,000 EUR.

Get free Innate Pharma S.A. - American Depositary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
12,469,000 EUR
Operating income
-2,793,000 EUR
Net income
-2,892,000 EUR
Operating cash flow
-10,967,000 EUR